Business Context and Reporting Period
Company: Chemed Corporation (CHEMED)
Filing Type: Form 10-Q (Unaudited Quarterly Report)
Period Ended: June 30, 2006
Business Overview: Chemed operates through two primary segments: VITAS Healthcare (hospice care services) and Roto-Rooter Group (plumbing and drain cleaning services). The company serves over 90% of the U.S. population through its Roto-Rooter network and provides end-of-life care through VITAS.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2006 |
Six Months Ended June 30, 2006 |
|---|---|---|
| Service Revenues and Sales | $249,783 | $496,021 |
| Income from Continuing Operations | $12,842 | $25,057 |
| Net Income | $12,842 | $25,057 |
| Diluted EPS (Continuing Ops) | $0.48 | $0.93 |
| Net Cash Provided by Operating Activities | N/A | $23,485 |
| Cash and Cash Equivalents (Ending) | $6,816 | $6,816 |
| Total Debt (Long-term + Current) | $169,604 | $169,604 |
| Available Credit (Revolving) | $124.7 million | $124.7 million |
Margins: Consolidated gross margin was 27.6% for the quarter and 27.7% for the six-month period. Income from continuing operations as a percent of revenue was 5.1% for both periods.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 10.4% for the quarter and 11.5% for the six months compared to the prior year.
- VITAS: Revenue grew 12% (quarter) and 14% (six months), driven by a 10% increase in Average Daily Census (ADC) and a 3% Medicare reimbursement rate increase. Growth was partially offset by a $2.3 million revenue reduction due to Medicare Cap limitations.
- Roto-Rooter: Revenue grew 7% (quarter) and 7% (six months), driven by a 6% price increase and a favorable shift toward higher-value commercial jobs.
- Profitability: Net income increased 44.5% for the quarter and 47.4% for the six months. This was driven by revenue growth outpacing SG&A expense growth and lower interest expense due to debt reduction.
- Liquidity: Cash and cash equivalents declined significantly from $57.1 million (Dec 31, 2005) to $6.8 million (June 30, 2006). This decrease was primarily due to the $65.5 million repayment of a term loan and $15 million funding for the "Costa case" legal settlement.
- Debt: Long-term debt decreased from $234.1 million to $169.4 million following the full repayment of an $84.4 million term loan in March 2006.
Guidance, Outlook, Risks, and Unusual Items
- Legal Contingencies:
- Costa Case: A class action lawsuit regarding wage and hour violations at VITAS was settled. The company funded $15 million in May 2006, with final court approval granted in June 2006. A pretax charge of $17.4 million was recorded in Q4 2005.
- OIG Investigation: The Office of Inspector General is investigating VITAS' billing practices. The company incurred $474,000 in pretax expenses for the six months ended June 30, 2006, to comply with requests. The outcome remains unpredictable.
- Roto-Rooter Litigation: A settlement regarding unlicensed employees in Illinois was approved by the court in July 2006 (subsequent to period end), with $3.1 million accrued in 2004.
- Medicare Cap Risk: Two VITAS programs reached the Medicare Cap revenue limitation in Q2 2006. Management estimates the total exposure for fiscal year 2006 to be between $4.0 million and $6.1 million.
- Share Repurchases: On July 27, 2006 (subsequent event), the company announced a new $50 million share repurchase program and intends to utilize the remaining $8 million from a prior program.
- Accounting Changes: The company adopted SFAS 123(R) for stock-based compensation effective January 1, 2006, using the modified prospective transition method. There was no material impact on financial position.
Investor Verification Checklist
- Medicare Cap Exposure: Verify the final impact of the Medicare Cap on VITAS revenues for the full fiscal year 2006, as the current estimate is a range ($4.0M - $6.1M).
- OIG Investigation Outcome: Monitor the status of the Office of Inspector General investigation and any potential qui tam intervention, as the financial impact is currently unpredictable.
- Liquidity Position: Confirm the company's ability to maintain liquidity given the significant cash outflow for debt repayment and legal settlements, leaving cash balances at $6.8 million.
- Debt Covenants: Verify continued compliance with financial covenants under the amended revolving credit facility, particularly given the reduction in cash reserves.
- Share Repurchase Execution: Track the execution of the newly announced $58 million total share repurchase program and its impact on capital structure.